Zeo Scientifix Inc (BPSR)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
BPSR Achieves Stable Growth Over Three-Month Period Ending January 31, 2024
Severe hit for Organicell Regenerative Medicine Inc during the fiscal interval ending April 30 2023
Serious Revenues drop, at amid the August to October 31 2022 time-frame
Top-line was $1.443474 millions at the company during the fiscal interval ending October 31 2022
The company disclosed surge in Revenues, during the third quarter of 2022 earnings season